Diagnostics company Nutromics has raised A$11 million ($7 million) ahead of its Series A funding round later this year.
WHAT IT'S FOR
The company has been raising funds for the imminent commercialisation of its continuous diagnostic monitoring technology.
Established in 2017, Nutromics has been developing a "lab-in-a-patch," which uses DNA sensor technology to track multiple targets, such as...
Azumio, a health and fitness platform, is tag-teaming with personal genomics company Helix to bring DNA sequencing to consumers.
The former is introducing full-exome DNA-based insights into its Calorie Mama AI app, with the goal of giving users a means of reaching their fitness goals through greater personalization. Calorie Mama AI is a smart camera app that simplifies calorie and nutrition...
More than a decade ago, when most people were still using not-so-smart mobile phones, the first human genome was sequenced. It cost $3 billion. In the time it took for smartphones to become the essential consumer technology, DNA sequencing rapidly evolved from a costly, uncommonly used process into a quick, reliable, relatively cheap and widely used predictive tool to give insight on disease risk...
